Aprea Therapeutics, Inc.

Biotechnology • Healthcare • Doylestown, PA, United States • APRE (NCM)

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.

215 948 4119 3805 Old Easton Road, Doylestown, PA 18902, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Aprea Therapeutics, Inc. (NASDAQ:APRE): Is Breakeven Near? - simplywall.st

simplywall.st • Dec 3

Aprea Therapeutics Highlights Clinical Progress and Strategic Plans in Shareholder Update Letter - Quiver Quantitative

Quiver Quantitative • Dec 18

HC Wainwright & Co. Maintains Aprea Therapeutics (APRE) Buy Recommendation - Nasdaq

Nasdaq • Dec 19

Hamill, Sr. VP at Aprea Therapeutics, buys $5,825 in stock By Investing.com - Investing.com UK

Investing.com UK • Dec 11

Director’s Bold Move: Major Stock Purchase in Aprea Therapeutics! - TipRanks

TipRanks • Dec 11

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Aprea Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Aprea Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Aprea Therapeutics, Inc. have?

Aprea Therapeutics, Inc. has approximately 8 employees.

What industry is Aprea Therapeutics, Inc. in?

Aprea Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Aprea Therapeutics, Inc. a publicly traded company?

Yes, Aprea Therapeutics, Inc. is publicly traded under the ticker symbol APRE on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Aprea Therapeutics, Inc. headquartered?

Aprea Therapeutics, Inc. is headquartered in Doylestown, PA, United States at 3805 Old Easton Road, Doylestown, PA 18902, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.